Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Operating Expenses: 2018-2024

Historic Operating Expenses for Eton Pharmaceuticals (ETON) over the last 7 years, with Dec 2024 value amounting to $26.0 million.

  • Eton Pharmaceuticals' Operating Expenses rose 59.12% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.8 million, marking a year-over-year increase of 50.46%. This contributed to the annual value of $26.0 million for FY2024, which is 16.87% up from last year.
  • Per Eton Pharmaceuticals' latest filing, its Operating Expenses stood at $26.0 million for FY2024, which was up 16.87% from $22.3 million recorded in FY2023.
  • Over the past 5 years, Eton Pharmaceuticals' Operating Expenses peaked at $26.9 million during FY2020, and registered a low of $20.5 million during FY2021.
  • For the 3-year period, Eton Pharmaceuticals' Operating Expenses averaged around $23.6 million, with its median value being $22.6 million (2022).
  • As far as peak fluctuations go, Eton Pharmaceuticals' Operating Expenses soared by 40.60% in 2020, and later fell by 23.69% in 2021.
  • Over the past 5 years, Eton Pharmaceuticals' Operating Expenses (Yearly) stood at $26.9 million in 2020, then decreased by 23.69% to $20.5 million in 2021, then rose by 10.14% to $22.6 million in 2022, then dropped by 1.44% to $22.3 million in 2023, then rose by 16.87% to $26.0 million in 2024.